News | Radiation Therapy | August 05, 2015

PetCure Oncology Launches National Veterinary Stereotactic Radiosurgery Centers Network

First centers open in Arizona and Ohio, with more locations planned nationwide

PetCure Oncology, stereotactic radiosurgery centers, network, SRS

August 5, 2015 — Pets are at risk of getting cancer just like humans. Of the estimated 70-80 million dogs and 74-96 million cats in the United States, cancer accounts for nearly 50 percent of all disease-related pet deaths and is the number one cause of death in older dogs and cats. In response to this unfortunate reality, Chicago-based PetCure Oncology, has launched a national network of veterinary radiosurgery centers.

What sets radiosurgery apart is that it is designed to cure, not merely ease the symptoms of cancer. Plus, it requires far fewer treatment sessions and dosing is more precise, so side effects are greatly reduced.

Although stereotactic radiosurgery (SRS), a form of radiation therapy, is widely available for treating human cancers, the veterinary field has a limited supply of advanced technology and services for treating the millions of pets in need.

“In most markets, radiation equipment is outdated, start-up costs are prohibitive and there’s a significant shortage of qualified veterinary radiation oncologists. In fact, there are fewer than 10 specialty centers in the nation that provide SRS for pets,” said Scott Milligan, PetCure Oncology CEO. “As a result, pet owners have had few options except to seek treatments that provide some comfort and pain management for as long as possible rather than cure the disease.”

The first location opened in May at Arizona Veterinary Oncology in Gilbert, Arizona. The second site will open in August in Cincinnati, Ohio, at Care Center. Many more locations across the country are in various stages of development.

For more information: www.petcureoncology.com

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Overlay Init